It has been reported that CGA could alleviate tumor necrosis factor-α (TNF-α) -induced cardiomyocyte injury by inhibiting the NF-κB and JNK signaling pathways, highlighting its cardioprotective potential in a TAC mouse model [52]. The gene discussed is TNF; the disease is persistent truncus arteriosus.